1
EXHIBIT 10.1
SETTLEMENT AGREEMENT AND FULL AND COMPLETE RELEASE
This Settlement Agreement and Full and Complete Release (the "Agreement"),
dated June 24, 1999, is made and entered into by and among Xxxxx X. Xxxxxxx
("Xxxxxxx"), Xxxxxx X. Xxxxxxx, Xxxxx X. Xxxxxxxx, Xxxx X. Xxxxxxx, Xxxxxxx X.
Xxxxxxx, the Xxxxx X. Xxxxxxx Retained Annuity Trust, and the Xxxxxxxx X.
Xxxxxxx Retained Annuity Trust (collectively the "MMS Shareholders"), on the one
hand, and Medaphis Corporation, a Delaware corporation (including its present
and former directors, officers, employees, agents, attorneys, and advisors)
("Medaphis"), on the other, in connection with the settlement (the "Settlement",
as described and defined more fully below) of the claims described below. The
MMS Shareholders and Medaphis are sometimes referred to hereinafter collectively
as the "Parties".
INTRODUCTION:
WHEREAS, Medaphis acquired Medical Management Sciences, Inc. ("MMS")
pursuant to the terms of a Merger Agreement dated as of December 29, 1995 (the
"Merger Agreement"), in a tax-free merger in which all of the shareholders of
MMS received shares of the Common Stock of Medaphis in exchange for their shares
of MMS (the "Merger");
WHEREAS, in connection with the closing of the Merger, Medaphis and certain
of the MMS Shareholders entered into an Indemnification Agreement dated as of
December 29, 1995 (the "Indemnification Agreement") relating to the agreements
by Medaphis and certain of the MMS Shareholders to provide certain
indemnification rights to each other in respect to losses, costs, expenses, and
other damages (including, but not limited to, attorneys' fees and expenses)
sustained as a result of a breach by the Parties of certain of their
representations, warranties, and covenants contained in the Merger Agreement or
in any MMS Ancillary Documents or Medaphis Ancillary Documents (as such terms
are defined in the Indemnification Agreement), as the case may be, or any
2
fraud, willful misconduct, bad faith, or intentional breach of any
representation, warranty, covenant, or agreement made by the signing parties,
all as more fully described in the Indemnification Agreement;
WHEREAS, Medaphis has sought indemnification from the MMS Shareholders for,
among other things, attorneys' fees and expenses arising out of or related to a
lawsuit known as Medical Billing, Inc. v. Medical Management Sciences, Inc., et
al., (N.D. Ohio) Case No. 1:94-CV-1567, and the related spoliation suit known as
Medical Billing, Inc., and Xxxxx, Xxxxxxxxxx & Xxxxxxx v. Medical Management
Sciences, Inc., et al., (N.D. Ohio) Case No. 1:96-CV-1015 (collectively the
"Cleveland Matters");
WHEREAS, the MMS Shareholders have asserted claims against Medaphis under
the Securities Act of 1933, as amended (the "Securities Act"), the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and related common law
and state statutory claims, for alleged damages that relate to or arise out of
certain alleged breaches in the representations and warranties of Medaphis
contained in the Merger Agreement, certain alleged material misstatements and
omissions in the Registration Statement/Prospectus delivered in connection with
the Merger, and certain other acts or omissions of Medaphis in connection with
the Merger, the Merger Agreement, and the Registration Rights Agreement
incorporated into the Merger Agreement;
WHEREAS, Medaphis has denied all liability and has raised counterclaims
against certain of the MMS Shareholders arising out of or relating to the Merger
and the Indemnification Agreement;
WHEREAS, the MMS Shareholders have denied all liability; and
WHEREAS, the Parties now desire to settle their differences arising out of
the above-referenced facts and the Merger.
3
AGREEMENT:
NOW, THEREFORE, IT IS HEREBY AGREED by and among the Parties that the
Released Claims (as defined below) are finally and fully compromised and
settled, as follows:
1.0 The Settlement Consideration.
1.1 The Settlement Shares and Settlement Warrants. Medaphis shall
deliver an aggregate Five Hundred Thousand (500,000) shares (the "Settlement
Shares") of Medaphis Common Voting Stock, par value $.01 per share ("Common
Stock"), and warrants to purchase an additional Five Hundred Thousand (500,000)
shares of Medaphis Common Voting Stock at a strike price equal to the closing
price per share of Medaphis common stock on the date that the parties execute
this agreement for a five-year period from the date of issuance, which warrants
shall contain other terms and conditions customary for securities of that type
("Settlement Warrants"), to the MMS Shareholders in accordance with the
percentages set forth on Schedule A hereto, subject to and in accordance with
the provisions set forth herein. Should any change be made to the capital stock
of Medaphis prior to the Closing (as defined below) by reason of any of any
stock split, stock dividend, recapitalization, combination of shares, exchange
of shares, or other change affecting the outstanding Common Stock as a class
without the receipt of consideration by Medaphis, or should any record date be
set with respect to such a matter on a date prior to the date of Closing,
appropriate adjustments shall be made to the number of Settlement Shares in
order to prevent the dilution or enlargement of the numbers of shares as a
proportion of the outstanding capital stock of Medaphis. In the case of (i) any
merger or consolidation in which securities possessing more than 50% of the
total combined voting power of Medaphis' outstanding securities are transferred
to a person or persons different from the persons holding those securities
immediately prior to such transaction, or (ii) the sale, transfer, or other
disposition of all or substantially all of Medaphis' assets (each of 1.1(i) and
(ii) being referred to as a "Corporate Transaction"),
4
in each case prior to the date on which the Settlement Shares or Settlement
Warrants have been issued occurring prior to Closing, or for which any record
date shall have been set prior to Closing, the MMS Shareholders shall thereafter
be entitled to receive the numbers of shares of stock or other securities or
other property (including cash) to which a holder of the Settlement Shares or
Settlement Warrants (as adjusted in the manner provided herein) would be
entitled to receive if all of the Settlement Shares or Settlement Warrants had
been issued on the record date of such Corporate Transaction. The MMS
Shareholders assume all market risk with respect to the Settlement Shares and
Settlement Warrants.
1.2 The Settlement Consulting Agreement. Medaphis shall enter into a
mutually agreeable consulting agreement with Providence Management Corp.
("Providence"), pursuant to which Providence will be paid Three Hundred Thousand
dollars ($300,000) upon execution of such consulting agreement and an additional
One Hundred Fifty Thousand dollars ($150,000) per year, payable monthly, for a
period of five years in exchange for Xxxxxxx'x performance, on behalf of
Providence, of such consulting services with respect to the MMS system and
Medaphis' practice management and billing and accounts receivable services to
physicians, including radiologists and radiation oncologists, as he may be
called upon by Medaphis to perform. The consulting agreement shall contain a
suitable provision barring Providence and its employees, including but not
limited to Xxxxxxx, from soliciting customers or employees of Medaphis. In
connection with such Agreement, Medaphis agrees to pay Providence's reasonable
and necessary business expenses incurred in connection with the consulting
services. Upon a change of control of Medaphis, before the end of Providence's
five year consulting agreement, Medaphis shall pay Providence the remaining
unpaid monthly payments for the duration of such consulting agreement, if any,
in one lump sum payment. Neither Providence nor Xxxxxxx will be considered a
Medaphis employee but
5
rather an independent contractor, in connection with the performance under such
consulting agreement.
1.3 Medaphis' Retention of Rights in the Xxxx, Xxxxxx & Parks
Matter. At the signing of this Agreement, Medaphis shall pay to the MMS
Shareholders (in amounts set forth on Schedule A hereto) an additional Three
Hundred Seventy- Five Thousand Dollars ($375,000) in connection with any
potential malpractice claim against Hahn, Loeser, & Parks ("HLP") arising from
or related to HLP's representation of the MMS Shareholders during the Cleveland
Matters; provided, however, that Medaphis shall retain the right to any
consideration received either by settlement or judgment from HLP. Moreover,
Medaphis shall have the sole control and discretion (a) to enter into any
settlement with HLP and (b) to decide what the terms and conditions of any such
settlement shall be, so long as such terms and conditions place or impose no
liabilities on the MMS Shareholders; and provided, further, that the MMS
Shareholders shall consent to and sign or execute any document or documents
necessary to effectuate such settlement.
1.4 MMS Release from the Indemnification Agreement. In addition to
the release set forth below, the MMS Shareholders shall be released from any
claim for indemnification arising under or related to the Indemnification
Agreement dated December 29, 1995 entered into in connection with the Merger
("Indemnification Agreement"), including without limitation, any claim based
upon the Cleveland Matters; provided, however, that Medaphis shall retain the
right to receive any recovery that Xxxxxxx or the MMS Shareholders may receive
from the Cleveland Matters; and provided, further, that Xxxxxxx agrees to
cooperate fully with Medaphis in the resolution of the Cleveland Matters and
further acknowledges and agrees that Medaphis has complete control over the
resolution of the Cleveland Matters.
1.5 Dismissal of Pending Litigation. Medaphis and the MMS Shareholders
shall cause the litigation known as Xxxxx X. Xxxxxxx, et. al., v. Medaphis
6
Corporation and Xxxxxxxx Xxxxx, (S.D.N.Y.) 97 CIV 2849 (WHP) (the "Litigation")
to be dismissed with prejudice as to all claims and counterclaims.
1.6 The Settlement Consideration. The "Settlement Consideration" shall
be the Settlement Shares, the Settlement Warrants, the Settlement Consulting
Agreement, and the other agreements contained in paragraphs 1.1 through 1.5 of
this Agreement.
2.0 Releases.
2.1 General Release by the MMS Shareholders. Upon the occurrence of the
Closing, each of the MMS Shareholders, severally, on behalf of himself, herself,
or itself, and for each and all of his, hers, or its respective partners
subsidiaries, affiliates (as defined in SEC Rule 12b-2), associates (as defined
in SEC Rule 12b-2), successors, assigns, heirs, and others claiming through or
under him, her, or it, shall have and shall hereby be deemed to have, fully,
finally, and forever released, relinquished, and discharged all "MMS Shareholder
Released Claims" (as defined below) against the "Medaphis Released Persons" (as
defined below).
(1) "MMS Shareholder Released Claims" collectively means all
claims, demands, rights, liabilities, and causes of action, known or unknown,
accrued or unaccrued, fixed or contingent, direct or derivative, individual or
representative, of every nature and description whatsoever, of the MMS
Shareholders against Medaphis from the beginning of time to the date of this
Agreement, including, without limitation, all claims that are asserted or that
could have been asserted by the MMS Shareholders arising out of or relating to
the purchase, sale, or ownership of Medaphis Common Stock, options, or other
Medaphis securities, or pursuant to or in connection with the Merger, or arising
out of or relating to any of the claimed acts, omissions, misrepresentations,
facts, events, matters, transactions, or occurrences referred to in the recitals
to this Agreement or as alleged in 1996 Medaphis Corporation Securities
Litigation, (N.D. Ga.), Civil Action No. 1:96-CV-2088-TWT, and Xxxxx X. Xxxxxxx,
et. al., v. Medaphis Corporation
7
and Xxxxxxxx X. Xxxxx, (S.D.N.Y.), Civil Action Xx. 00 Xxx. 0000 (XXX) ("Xxxxxxx
Litigation"), including, without limitation, any of Medaphis' restatements of
any of its financial statements, excepting from such release only those rights
and obligations created or preserved by this Agreement.
(2) "Medaphis Released Persons" means Medaphis and each of its
respective past or present directors; employees; partners; principals; agents;
underwriters; issuers; insurers; con-insurers; reinsurers; shareholders;
attorneys (including, without limitation, King & Spalding; Xxxxxxx Xxxx, Slate,
Meager & Xxxx LLP; Paul, Hastings, Xxxxxxxx & Xxxxxx; and any present and former
partners or employees thereof); accountants; investment bankers; advisors;
securities analysts; brokerage firms; personal representatives; predecessors;
successors; parents; subsidiaries; divisions; assigns; spouses; heirs;
associates (as defined by SEC Rule 12b-2); affiliates (as defined by SEC Rule
12b-2) and any members of their immediate families; any person, firm, trust,
corporation, officer, director, or other individual or entity in which any of
the above persons has a controlling interest, or which is related to or
affiliated with any of the above persons; or any trust of which any of the above
persons is the settlor or which is for the benefit of any of the above persons
and/or member(s) of his family; and any individual, group, or entity who
directly or indirectly participated in the dissemination of information about
Medaphis or who directly or indirectly is responsible for any of the damages
alleged by the MMS Shareholders, including, without limitation, any securities
analysts or brokerage firms.
2.2 General Release by Medaphis. Upon Closing, Medaphis, on behalf of
itself and for each and all of its respective subsidiaries, affiliates, (as
defined in SEC Rule 12b-2), associates (as defined in SEC Rule 12b-2),
successors, assigns, and others claiming through or under it, shall have and
shall hereby be deemed to have, fully, finally, and forever released,
relinquished, and discharged all "Medaphis Released
8
Claims" (as defined below) against the "MMS Shareholder Released Persons" (as
defined below).
(1) "Medaphis Released Claims" collectively means all claims,
demands, rights, liabilities, and causes of action, known or unknown, accrued or
unaccrued, fixed or contingent, direct or derivative, individual or
representative, of every nature and description whatsoever, from the beginning
of time down to the date of this Agreement, including without limitation: all
claims that Medaphis has or could assert against Xxxxxxx under the non-compete
agreement that Xxxxxxx entered into in connection with the Merger; all claims
that are asserted or that could have been asserted by Medaphis arising out of or
relating to the Merger; all claims that are asserted or could have been asserted
by Medaphis arising out of the Registration Rights Agreement incorporated in the
Merger Agreement; all claims that are asserted or could have been asserted by
Medaphis arising out of the Indemnification Agreement dated December 29, 1995
entered into in connection with the Merger; and all claims for indemnification
that are asserted or could have been asserted by Medaphis as a result of the
litigation known as Medical Billing, Inc. v. Medical Management Sciences, Inc.,
et al., (N.D. Ohio), Case No. 1:94-CV-1567 and the related spoliation suit known
as Medical Billing, Inc., and Xxxxx, Xxxxxxxxxx & Xxxxxxx v. Medical Management
Sciences, Inc., et al., (N.D. Ohio), Case No. 1:96-CV-1015 (the "Cleveland
Matters"); excepting therefrom only those rights and obligations created or
preserved by this Agreement; provided, however, that Medaphis shall retain the
right to receive any recovery that Xxxxxxx or the MMS Shareholders may receive
from the Cleveland Matter.
(2) "MMS Shareholder Released Persons" means each of the MMS
Shareholders and each of his, hers, or its respective past or present directors,
officers, employees, partners, principals, agents, underwriters, issuers,
insurers, co- insurers, reinsurers, shareholders, attorneys, (including, without
limitation Xxxxxx, Xxxxx & Xxxxx LLP; and any present or former partners or
employees of the foregoing firm),
9
accountants, investment bankers, advisors, securities analysts, brokerage firms,
predecessors, successors, parents, subsidiaries, divisions, assigns, associates
(as defined by SEC Rule 12b-2), and affiliates (as defined by SEC Rule 12b-2).
2.3 Released Claims. The Medaphis Released Claims, as defined in
paragraph 2.2 (a) of this Agreement, and the MMS Shareholder Released Claims, as
defined in paragraph 2.1 (a) of this Agreement, sometimes are referred to
collectively as the "Released Claims".
2.4 California Civil Code.
Effective as of the Closing and the giving of the releases
described above, the Parties knowingly, voluntarily, and expressly waive and
relinquish any and all rights that they may have under Section 1542 of the
California Civil Code, or any similar provision or law of any jurisdiction or
any similar or analogous principle of common law. California Civil Code Section
1542 provides:
A general release does not extend to claims which the creditor
does not know or suspect to exist in his favor at the time of
executing the release, which if known by him must have
materially affected his settlement with the debtor.
3.0 Registration of Settlement Shares
3.1 Resale Registration Statement. Medaphis shall prepare and file
with the Securities and Exchange Commission (the "Commission") as soon as
practicable after the date hereof a registration statement (the "Registration
Statement) on Form S-3 or other available form with respect to resale of the
Settlement Shares by the MMS Shareholders and shall use its reasonable best
efforts to have the Registration Statement declared effective by the Commission
as promptly as practicable thereafter. Medaphis and each of the MMS Shareholders
will cooperate in the preparation of the Registration Statement for the
Settlement Shares and will furnish each other with all information concerning
themselves, and such other matters as may be reasonably necessary or
10
advisable for the Registration Statement, filings under the state securities
laws, and any other statement or application made by or on behalf of Medaphis or
any of the MMS Shareholders to any governmental body in connection with this
Settlement Agreement and the transactions contemplated hereby. Medaphis shall
provide a reasonable opportunity for the MMS Shareholders to review a draft of
the Registration Statement, and any amendment or supplement thereto, and to
correct any information with respect to the MMS Shareholders prior to the time
the Registration Statement is filed with the Commission. Medaphis agrees to
maintain the effectiveness of the Registration Statement from the date on which
the Commission declares the Registration Statement to be effective through the
first to occur of (i) the first anniversary of the Closing and the effectiveness
of the respective releases provided under Section 2.0; (ii) the date on which
each of the MMS Shareholders is no longer subject to any restriction on resale
pursuant to Rule 144 promulgated under the Securities Act ("Rule 144"); and
(iii) the date on which each of the MMS Shareholders shall have sold all of the
Settlement Shares held by such person. Notwithstanding the preceding sentence,
if the Board of Directors of Medaphis determines in good faith that it is in the
best interests of the stockholders of Medaphis not to disclose the existence of
facts surrounding any proposed or pending acquisition, disposition, strategic
alliance, financing transaction, or other pending material event involving
Medaphis, Medaphis, by written notice to the MMS Shareholders, may suspend the
rights of the MMS Shareholders to make sales pursuant to the Registration
Statement; provided that such period of suspension shall not exceed forty-five
(45) days during the period in which the Registration Statement is required to
remain effective as provided herein. In addition to the foregoing, in connection
with the preparation, filing, and effectiveness of the Registration Statement,
Medaphis will:
(a) prepare and file with the Commission such amendments and
supplements to the Registration Statement and the prospectus used in
connection therewith as may be necessary to keep the Registration Statement
effective for such
11
period as may be required hereunder, and in each case to comply with
provisions of the Securities Act with respect to the disposition of the
Settlement Shares during such period in accordance with the intended
methods of distribution by the MMS Shareholders set forth in the
Registration Statement;
(b) furnish the MMS Shareholders such number of copies of the
Registration Statement, each amendment and supplement thereto, in each
case including all exhibits, the prospectus included in the Registration
Statement, and such other documents as the MMS Shareholders may reasonably
request in order to facilitate the disposition of the Settlement Shares by
the MMS Shareholders;
(c) use its reasonable best efforts to register or qualify the
Settlement Shares under such other securities or blue sky laws of such
jurisdictions within the United States as the MMS Shareholders reasonably
requests to keep such registration or qualification in effect for as long
as the Registration Statement is in effect and to do any and all other
acts and things which may be reasonably necessary or advisable to enable
the MMS Shareholders to consummate the disposition in such jurisdictions
of the Settlement Shares then held or owned by the MMS Shareholders;
(d) at any time when a prospectus relating to the resale of
Settlement Shares is required to be delivered under the Securities Act, to
notify the MMS Shareholders of the happening of any event as a result of
which the prospectus contained in the Registration Statement contains an
untrue statement of material fact or omits any facts necessary to make the
statements therein not misleading, and promptly prepare a supplement or
amendment to such prospectus so that, as thereafter delivered to the
purchasers of Settlement Shares, such prospectus will not contain an
untrue statement of material fact or omit to state any fact necessary to
make the statements therein, in light of the circumstances under which
statements were made, not misleading;
(e) If the Registration Statement has been filed on Form S-3
or any other available form promulgated by the Commission permitting the
incorporation of
12
Medaphis's Commission reports or other documents by reference, and if such
short form thereafter becomes unavailable for use by Medaphis for any reason,
Medaphis shall promptly as practicable thereafter take such steps as are
necessary to convert the Registration Statement into a registration statement on
Form S-1 or other available long form, including, but not limited to, by
post-effective amendment, and shall use commercially reasonable efforts to cause
such long-form registration statement to become effective as promptly as
practicable thereafter and to otherwise comply with the provisions of this
Section 3.1.
3.2 Exchange Act Reports. From and after the date hereof, and for so
long as is necessary in order to permit the MMS Shareholders to sell the
Settlement Shares pursuant to Rule 144 and to maintain the availability to
Medaphis of Form S-3 or other available short-form registration statement
permitting the incorporation of Medaphis's Commission reports or other documents
by reference, Medaphis will file on a timely basis all reports and other
documents required to be filed by it pursuant to the Securities Act, and the
Exchange Act, including Section 13 or 15(d) thereof; and to furnish to any MMS
Shareholder, so long as such MMS Shareholder owns any Settlement Shares,
forthwith upon request (i) a written statement by Medaphis that it has complied
with reporting requirements of Rule 144, the Securities Act, and the Exchange
Act, or that it qualifies as a registrant whose securities may be issued or
resold pursuant to Form S-3 (or any other available short-form registration
statement), (ii) a copy of the most recent annual or quarterly report of
Medaphis and such other reports and documents so filed by Medaphis (including
all exhibits), and (iii) such other information as may be reasonably requested
in availing any MMS Shareholder of any rule or regulation of the Commission
which permits the selling of any such securities of Medaphis without
registration or pursuant to Form S-3 or other available short-form registration
statement.
13
3.3 Payment of Certain Expenses.
(a) Registration Statement. Medaphis shall bear and pay all
expenses incurred in connection with the preparation, filing, and
maintenance of the Registration Statement provided for under Section
3.1, including, without limitation, all registration, filing, and
qualification fees, printer and accounting fees, but excluding any
underwriters' or brokers' discounts or commissions associated with the
resale of the Settlement Shares, which discounts or commissions shall
be borne by the MMS Shareholder incurring same;
(b) Share Transfers and Opinions. If at any time after the one-year
period specified in subsection (d)(1) of Rule 144, any MMS Shareholder
shall not be an affiliate of Medaphis, Medaphis agrees (i) to cooperate
with such MMS Shareholder in connection with the removal of legends
placed on such MMS Shareholder's Settlement Shares pursuant to Section
5.0 hereof, (ii) not to require legal opinions with respect to the
transfer of such Settlement Shares after expiration of such one-year
holding period (or if it does to issue or cause to be issued such
opinion at its own expense), and (iii) to otherwise bear all expenses
associated with reissuing such shares without legends or in connection
with the issuance of any opinions requested by Medaphis or its transfer
agent with respect to the transfer of such shares.
14
4.0 Closing. The consummation of the transactions contemplated by the
Agreement shall take place at the offices of King & Spalding, 000 Xxxxxxxxx
Xxxxxx, Xxxxxxx, Xxxxxxx 00000, on June , 1999, or such other date and place
as the parties shall agree (which time and place are designated as the
"Closing").
5.0 Acknowledgment, Representations and Warranties of MMS Shareholders.
Each of the MMS Shareholders acknowledges that the issuance of the Settlement
Shares will not be registered under the Securities Act, or any applicable state
securities laws, in reliance upon exemptions from registration contained in the
Securities Act and such state laws, and that Medaphis's reliance upon such
exemptions is based in part upon each of the MMS Shareholder's representations,
warranties, and agreements contained in this Agreement. Each Recipient
acknowledges that, prior to the execution of this Agreement, such MMS
Shareholder has had the opportunity to ask questions of and receive answers to
obtain additional information from a representative of Medaphis concerning the
financial and other affairs of Medaphis and the terms and conditions of the
issuance of the Settlement Shares, and, to the extent such MMS Shareholder
believes necessary in light of its personal knowledge of Medaphis' affairs, such
MMS Shareholder has asked such questions and received satisfactory answers.
Each of the MMS Shareholders further represents, warrants, and agrees
as follows:
(a) Such MMS Shareholder shall not make any sale, transfer, or
other disposition of the Settlement Shares without registration under the
Securities Act and any applicable state securities laws unless an
exemption from such registration is available and is complied with;
(b) such MMS Shareholder is familiar with the business in
which Medaphis is engaged, and based upon its knowledge and experience in
financial and business matters, such MMS Shareholder is familiar with the
15
investments of the sort which he, she, or it is undertaking by receiving
the Shares; such MMS Shareholder is fully aware of the problems and risks
involved in making an investment of this type; and such MMS Shareholder is
capable of evaluating the merits and risks of this investment;
(c) that the investment which the MMS Shareholder is undertaking by
receiving the Settlement Shares is in accord with the nature and size of
such MMS Shareholder's present investments and net worth, and such MMS
Shareholder is financially above to bear the economic risk of this
investment;
(d) that there will be placed on the certificates for the Settlement
Shares, or any substitutions therefor, a legend stating in substance as
follows:
"The shares evidenced by this certificate have not been registered
under the Securities Act of 1933, as amended, and may not be
transferred, nor will any assignee or endorsee hereof be recognized as
an owner hereof by the issuer for any purpose, unless a registration
statement under the Securities Act of 1933, as amended, with respect to
such shares shall then be in effect or unless the availability of an
exemption from registration with respect to any proposed transfer or
disposition of such shares shall be established to the satisfaction of
counsel for the issuer. In addition, these securities have not been
registered or qualified under the securities laws of any state and may
not be sold or transferred except in a transaction which is exempt under
the applicable state securities laws or pursuant to an effective
registration or qualification under such laws.";
(e) that all information with respect to such MMS Shareholder
contained in the Registration Statement and any prospectus used in
connection therewith is true and correct in all material respects as of the
date hereof; and
16
(f) that such MMS Shareholder is an "accredited investor" as such term
is defined in rule 501(a) under the Securities Act.
6.0 Additional Agreements.
6.1 Reservation of Shares. Subject to the following sentence, Medaphis
will at all times reserve and keep available out its authorized but unissued
shares of Medaphis Common Stock, solely for the purpose of satisfying its
obligations hereunder, up to one million (1,000,000) shares of Common Stock. If
at any time the number of authorized but unissued shares of Common Stock shall
not be sufficient to permit Medaphis to perform its obligations hereunder, in
addition to such other remedies as shall be available to the MMS Shareholders at
law or in equity, Medaphis will use its reasonable best efforts to take such
corporate action as is necessary to increase the number of authorized but
unissued shares of Common Stock to such number of shares as shall be sufficient
for such purpose, including, without limitation, using its reasonable best
efforts to obtain the requisite stockholder approval of any necessary amendment
to increase its authorized capital stock under its Certificate of Incorporation,
as the same has been or may be amended from time to time.
6.2 Public Announcements. Each of the MMS Shareholders and their
counsel agree not to disclose the existence or terms of this Agreement to any
person until after public disclosure of the settlement by Medaphis. Any
subsequent public disclosure of the existence or terms of this Agreement by any
of the MMS Shareholders or their counsel will be subject to Medaphis' prior
review and consent, which consent will not be unreasonably withheld.
17
6.3 Further Assurances. Each Party will diligently perform all acts,
and execute and deliver all documents, reasonably necessary to effect all
provisions of this Agreement.
6.4 Tax Matters. The Parties agree that, for Federal and state income
tax purposes, they will treat and report the issuance of the Settlement Shares,
the Settlement Warrants, and the Settlement Consulting Agreement as additional
consideration delivered to the MMS Shareholders in connection with the Merger,
with no portion being treated or reported as imputed interest. The Parties
further agree not to take any position inconsistent with such treatment before
any taxing or other governmental authorities.
7.0 Termination.
7.1 Termination and Abandonment. This Agreement may be terminated at
any time prior to Closing by written agreement among Medaphis and each of the
MMS Shareholders.
7.2 Effect of Termination. In the event of termination of this
Agreement, this Agreement shall forthwith become void and each party shall be
returned to its position prior to entering into this Agreement. The Settlement
Stock and Settlement Warrants shall be returned to Medaphis. Any Judgment or
Order of Dismissal entered as a result of or in accordance with this Agreement
shall be treated as vacated, nunc pro tunc, and the Parties shall be restored to
their respective positions in the litigation.
8.0 Miscellaneous Provisions.
8.1 Cooperation and Intent. The Parties agree to the following:
(1) That it is their intent to consummate this Agreement; and
(2) That they agree to cooperate to the extent necessary to
effectuate and implement all terms and conditions of the Stipulation and,
subject to their
18
fiduciary obligations, to exercise their reasonable best efforts to promptly
accomplish the terms and conditions of this Agreement.
8.2 No Admission of Liability. Neither this Agreement nor any act
performed or document executed pursuant to or in furtherance of this Agreement
or the Settlement:
(a) Is or may be deemed to be, or may be used as an admission of,
or evidence of, the validity of any Released Claim, or of any alleged wrongdoing
or liability of Medaphis, the Medaphis Released persons, the MMS Shareholders or
the MMS Shareholder Released Persons or any of them; or
(b) Is or may be deemed to be, or may be used as an admission of,
or evidence of, any alleged fault or omission of Medaphis, any MMS Shareholder,
any MMS Shareholder Released Persons or any Medaphis Released Persons, in any
civil, criminal, or administrative proceeding in any court, administrative
agency, or other tribunal, other than in such proceedings as may be necessary to
consummate or enforce this Agreement, except that Medaphis, any MMS
Shareholders, any MMS Shareholder Released Person, or any Medaphis Released
persons, or any of them, may, upon at least five days prior written notice to
the non-disclosing Parties, file the Agreement in any action that may be brought
against them in order to support a claim, defense, or counterclaim based on
principles of res judicata, collateral estoppel release, judgment bar or
reduction, or any other theory of claim preclusion or issue preclusion or
similar claim, defense, or counterclaim.
8.3 Good Faith: Benefit of Counsel. Each of the Parties intend the
Agreement to be final and complete resolution of all disputes asserted which
could be asserted by such Party against Medaphis or any MMS Shareholders, as
applicable, and the MMS Shareholder Released Persons or Medaphis Released
Persons with respect to the Released Claims. The Parties agree that the amount
paid and the other terms of the
19
Agreement were negotiated at arms' length in good faith by the Parties and
reflect a Settlement that was reached voluntarily after consultation with
experienced counsel.
8.4 Entire Agreement. This Agreement constitutes the entire agreement
among the Parties with respect to the subject matter hereof, and no
representations, warranties, or inducements have been made to any Parties
concerning the foregoing other than the representations, warranties, and
covenants contained and memorialized in this Agreement. The Parties further
agree, to the extent permitted by law, that all previous agreements that were
made, if any, relating to the confidentiality of information and requirements
for return or destruction of documents shall survive this Agreement.
8.5 Ownership of Claims. Each of the Parties warrants and represents
that: (i) such Party has not prior to the date hereof sold, transferred,
conveyed, encumbered, or assigned any portion of such rights as are being
settled and released in this Agreement; and (ii) such Party is the sole and
exclusive holder of such rights.
8.6 Counterparts. This Agreement may be executed in or more
counterparts. All executed counterparts and each of them shall be deemed to be
one and the same instrument. Counsel for the Parties shall exchange among
themselves original signed counterparts.
8.7 Successor and Assigns. This Agreement shall be binding upon, and
inure to the benefit of, the successors and assigns of the Parties hereto.
8.8 Governing Law. This Agreement shall be considered to have been
negotiated, executed, and delivered, and to be wholly performed, in the State of
Georgia, and the rights and obligations of the Parties to this Agreement shall
be governed by, construed, and enforced in accordance with the laws of the State
of Georgia without giving effect to that state's choice of law or conflicts of
law principles.
8.9 Amendments; Waivers. This Agreement may be modified only by a
written instrument signed by all the Parties hereto.
20
8.10 Expenses. Medaphis and the MMS Shareholders will bear their own
expenses with respect to the negotiation, execution, and delivery of the
Agreement and the performance of their obligations hereunder, unless stated
otherwise expressly herein.
8.11 Headings. The headings of the several sections and subsections of
this Agreement are for convenience or reference only and are not intended to
supplement or change the terms of this Agreement.
IN WITNESS WHEREOF, the undersigned Parties have executed this
Settlement Agreement and Release effective as of the date first set forth above.
Dated: 6/24/99
-------------------------------------
MEDAPHIS CORPORATION
By: /s/ XXXXXXXX X. X. XXXXX
------------------------------
Name: Xxxxxxxx X. X. Xxxxx
------------------------------
Title: Executive Vice President
------------------------------
XXXXX X. XXXXXXX
/s/ XXXXX X. XXXXXXX
-------------------------------------
XXXXXX X. XXXXXXX
/s/ XXXXXX X. XXXXXXX
-------------------------------------
XXXXX X. XXXXXXXX
/s/ XXXXX X. XXXXXXXX
-------------------------------------
21
XXXX X. XXXXXXX
/s/ XXXX X. XXXXXXX
-------------------------------------
XXXXXXX X. XXXXXXX
/s/ XXXXXXX X. XXXXXXX
-------------------------------------
THE XXXXX X. XXXXXXX RETAINED ANNUITY TRUST
By: /s/ XXXXX X. XXXXXXX
-------------------------------------
Name: Xxxxx X. Xxxxxxx
-------------------------------------
Title: Trustee
-------------------------------------
XXXXXXXX X. XXXXXXX RETAINED ANNUITY TRUST
By: /s/ XXXXX X. XXXXXXX
-------------------------------------
Name: Xxxxx X. Xxxxxxx
-------------------------------------
Title: Trustee
-------------------------------------
22
SCHEDULE A
TO
SETTLEMENT AGREEMENT AND FULL AND COMPLETE RELEASE
PERCENTAGE OF SHARES
SHAREHOLDER AND WARRANTS
----------- --------------------
Xxxxx X. Xxxxxxx 50.858
Xxxxx X. Xxxxxxx
Retained Annuity Trust 15.198
Xxxxxxxx X. Xxxxxxx
Retained Annuity Trust 15.198
Xxxxxx X. Xxxxxxx 5.998
Xxxxx X. Xxxxxxxx 5.998
Xxxx X. Xxxxxxx 5.998
Xxxxxxx X. Xxxxxxx 0.752
